Literature DB >> 12912976

Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.

Daniele Santini, Bruno Vincenzi, Giuseppe Tonini, Susanna Scarpa, Alfonso Baldi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12912976

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  3 in total

1.  Effects of high dose of zoledronic acid on superficial vascular network of membranous bone sites: an intravital study on rat calvarium.

Authors:  M H Vieillard; J Paccou; B Cortet; E Biver; J Salleron; G Falgayrac; G Penel
Journal:  Osteoporos Int       Date:  2009-12-18       Impact factor: 4.507

2.  Lymphoid Enhancer Factor 1 Contributes to Hepatocellular Carcinoma Progression Through Transcriptional Regulation of Epithelial-Mesenchymal Transition Regulators and Stemness Genes.

Authors:  Chih-Li Chen; Yu-Shuen Tsai; Yen-Hua Huang; Yuh-Jin Liang; Ya-Yun Sun; Chien-Wei Su; Gar-Yang Chau; Yi-Chen Yeh; Yung-Sheng Chang; Jui-Ting Hu; Jaw-Ching Wu
Journal:  Hepatol Commun       Date:  2018-09-28

3.  Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw.

Authors:  Bruno Vincenzi; Andrea Napolitano; Alice Zoccoli; Michele Iuliani; Francesco Pantano; Nicola Papapietro; Vincenzo Denaro; Daniele Santini; Giuseppe Tonini
Journal:  J Hematol Oncol       Date:  2012-09-17       Impact factor: 17.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.